Terms: = Lung cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
880 results:
1. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
[TBL] [Abstract] [Full Text] [Related]
2. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
Liu X; Li J; Huang Q; Jin M; Huang G
Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small-cell lung cancer.
Zhang X; Wang X; Wen Y; Chen S; Zhou C; Wu F
Clin Transl Med; 2024 Apr; 14(4):e1649. PubMed ID: 38629624
[TBL] [Abstract] [Full Text] [Related]
4. Photodynamic therapy upregulates expression of HIF-1α and PD-L1 in related pathways and its clinical relevance in non-small-cell lung cancer.
Sun W; Cheng Y; Ma X; Jin Z; Zhang Q; Wang G
Eur J Med Res; 2024 Apr; 29(1):230. PubMed ID: 38609977
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
D'Antona S; Porro D; Gallivanone F; Bertoli G
Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
[TBL] [Abstract] [Full Text] [Related]
6. Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma.
Hao B; Dong H; Xiong R; Song C; Xu C; Li N; Geng Q
Comput Biol Med; 2024 Mar; 171():108183. PubMed ID: 38422959
[TBL] [Abstract] [Full Text] [Related]
7. Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic lung cancer Therapy.
Wang MM; Deng DP; Zhou AM; Su Y; Yu ZH; Liu HK; Su Z
Inorg Chem; 2024 Mar; 63(10):4758-4769. PubMed ID: 38408314
[TBL] [Abstract] [Full Text] [Related]
8. [Combination of shikonin and gefitinib reverses drug resistance in human non-small cell lung cancer and its mechanism].
Ai XY; Hou XF; Feng NP
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):175-184. PubMed ID: 38403350
[TBL] [Abstract] [Full Text] [Related]
9. Influence of
Naqash AR; Floudas CS; Aber E; Maoz A; Nassar AH; Adib E; Choucair K; Xiu J; Baca Y; Ricciuti B; Alessi JV; Awad MM; Kim C; Judd J; Raez LE; Lopes G; Nieva JJ; Borghaei H; Takebe N; Ma PC; Halmos B; Kwiatkowski DJ; Liu SV; Mamdani H
JCO Precis Oncol; 2024 Feb; 8():e2300371. PubMed ID: 38330261
[TBL] [Abstract] [Full Text] [Related]
10. β-Caryophyllene Inhibits Endothelial Tube Formation by Modulating the Secretome of Hypoxic lung cancer Cells-Possible Role of VEGF Downregulation.
Wittig F; Koch F; Pannenberg L; Bekeschus S; Ramer R; Hinz B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255884
[TBL] [Abstract] [Full Text] [Related]
11. The knockdown of stathmin with si-RNA inhibits invasion of mesothelioma.
Aksoy A; Varoglu A; Onalan EE; Tektemur A; Artas G; Koc M; Cakmak M; Aydin S; Kilic M; Ulas M
Tissue Cell; 2024 Apr; 87():102303. PubMed ID: 38244401
[TBL] [Abstract] [Full Text] [Related]
12. MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.
Santamans AM; Cicuéndez B; Mora A; Villalba-Orero M; Rajlic S; Crespo M; Vo P; Jerome M; Macías Á; López JA; Leiva M; Rocha SF; León M; Rodríguez E; Leiva L; Pintor Chocano A; García Lunar I; García-Álvarez A; Hernansanz-Agustín P; Peinado VI; Barberá JA; Ibañez B; Vázquez J; Spinelli JB; Daiber A; Oliver E; Sabio G
Sci Adv; 2024 Jan; 10(3):eadk6524. PubMed ID: 38241373
[TBL] [Abstract] [Full Text] [Related]
13. A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.
Chen L; Xu G; Song X; Zhang L; Chen C; Xiang G; Wang S; Zhang Z; Wu F; Yang X; Zhang L; Ma X; Yu J
Cancer Lett; 2024 Feb; 583():216635. PubMed ID: 38237887
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.
Liu W; Du Q; Mei T; Wang J; Huang D; Qin T
BMC Cancer; 2024 Jan; 24(1):94. PubMed ID: 38233752
[TBL] [Abstract] [Full Text] [Related]
15. DNMT3a-mediated upregulation of the stress inducible protein sestrin-2 contributes to malignant transformation of human bronchial epithelial cells following nickel exposure.
Wang X; Tian Z; He L; Meng H; Zhu J; Li Y; Wang J; Hua X; Huang H; Huang C
Ecotoxicol Environ Saf; 2024 Feb; 271():115954. PubMed ID: 38232523
[TBL] [Abstract] [Full Text] [Related]
16. The HIF-1α/PKM2 Feedback Loop in Relation to EGFR Mutational Status in lung Adenocarcinoma.
Wang Y; Lian H; Li J; Zhao M; Hao Z; Zheng X; Zhao L; Cui J
J Invest Surg; 2024 Dec; 37(1):2301081. PubMed ID: 38224012
[TBL] [Abstract] [Full Text] [Related]
17. UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF-1α signaling.
Song C; Liu Q; Qin J; Liu L; Zhou Z; Yang H
Cancer Med; 2024 Feb; 13(3):e6938. PubMed ID: 38217303
[TBL] [Abstract] [Full Text] [Related]
18. Combination of the cuproptosis inducer disulfiram and anti‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway.
Li P; Sun Q; Bai S; Wang H; Zhao L
Int J Mol Med; 2024 Feb; 53(2):. PubMed ID: 38186308
[TBL] [Abstract] [Full Text] [Related]
19. Spatial features of specific CD103
Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
J Transl Med; 2024 Jan; 22(1):27. PubMed ID: 38183111
[TBL] [Abstract] [Full Text] [Related]
20. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
[Next]
